Uscom 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Rob Phillips

최고 경영자

AU$513.2k

총 보상

CEO 급여 비율	48.9%
CEO 임기	no data
CEO 소유권	33.7%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	6.3yrs

최근 관리 업데이트

Recent updates

Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Jan 25

Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Dec 01

CEO 보상 분석

Rob Phillips 의 보수는 Uscom 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	AU$513k	AU$251k	-AU$2m
Mar 31 2024	n/a	n/a	-AU$2m
Dec 31 2023	n/a	n/a	-AU$2m
Sep 30 2023	n/a	n/a	-AU$2m
Jun 30 2023	AU$439k	AU$251k	-AU$3m
Mar 31 2023	n/a	n/a	-AU$3m
Dec 31 2022	n/a	n/a	-AU$2m
Sep 30 2022	n/a	n/a	-AU$2m
Jun 30 2022	AU$544k	AU$251k	-AU$2m
Mar 31 2022	n/a	n/a	-AU$2m
Dec 31 2021	n/a	n/a	-AU$2m
Sep 30 2021	n/a	n/a	-AU$1m
Jun 30 2021	AU$723k	AU$251k	-AU$924k
Mar 31 2021	n/a	n/a	-AU$514k
Dec 31 2020	n/a	n/a	-AU$105k
Sep 30 2020	n/a	n/a	-AU$718k
Jun 30 2020	AU$352k	AU$251k	-AU$1m
Mar 31 2020	n/a	n/a	-AU$2m
Dec 31 2019	n/a	n/a	-AU$2m
Sep 30 2019	n/a	n/a	-AU$2m
Jun 30 2019	AU$265k	AU$240k	-AU$1m
Mar 31 2019	n/a	n/a	-AU$2m
Dec 31 2018	n/a	n/a	-AU$2m
Sep 30 2018	n/a	n/a	-AU$2m
Jun 30 2018	AU$337k	AU$229k	-AU$2m

보상 대 시장: Rob 의 총 보상 ($USD 333.62K )은 Australian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 298.27K ).

보상과 수익: 회사가 수익성이 없는 동안 Rob 의 보상이 증가했습니다.

CEO

Rob Phillips (71 yo)

no data

테뉴어

AU$513,177

보상

Dr. Robert Allan Phillips, also known as Rob, Ph D.(Med), MPhil (Med), FASE, DMU, AMS, FIR, is the Founder of Uscom Limited and serves as its Chief Scientist. Dr. Phillips has been the Chief Executive Offi...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Robert Phillips	Founder	no data	AU$513.18k	33.65% A$ 2.7m
Brett Crowley	Company Secretary & Non-Executive Director	6.3yrs	AU$52.15k	0.080% A$ 6.4k
Peter Lichtenthal	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Colin Sullivan	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Malcolm West	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Stephane Carlier	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Chu-Pak Lau	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Xianhui Meng	Non-Executive Director	4.9yrs	AU$38.63k	21.93% A$ 1.8m
Christian Bernecker	Independent Non-Executive Director	13yrs	AU$38.33k	데이터 없음
Didier Payen	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음
Nigel Sharrock	Member of Medical & Technology Advisory Board	no data	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 이사회: UCM 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.

Uscom 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Uscom Limited, Annual General Meeting, Oct 25, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Oct 26, 2023

Recent updates

Uscom Limited, Annual General Meeting, Oct 25, 2024

Full year 2024 earnings released: AU$0.012 loss per share (vs AU$0.015 loss in FY 2023)

New minor risk - Financial data availability

New minor risk - Shareholder dilution

First half 2024 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2023)

Uscom Limited has filed a Follow-on Equity Offering in the amount of AUD 2.014212 million.

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Oct 26, 2023

Less than half of directors are independent

Less than half of directors are independent

New major risk - Revenue and earnings growth

Full year 2023 earnings released: AU$0.015 loss per share (vs AU$0.011 loss in FY 2022)

Less than half of directors are independent

Uscom Limited (ASX:UCM) announces an Equity Buyback for 19,676,833 shares, representing 9.91% for AUD 1.08 million.

Less than half of directors are independent

First half 2023 earnings released: AU$0.008 loss per share (vs AU$0.006 loss in 1H 2022)

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Nov 10, 2022

Full year 2022 earnings released: AU$0.011 loss per share (vs AU$0.006 loss in FY 2021)

Less than half of directors are independent

Uscom Limited to Be Deleted from Other OTC

Uscom Limited Releases Details of A Study Confirming the High Accuracy of the Uscom BP+ Central Blood Pressure Monitor

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

Uscom Limited Announces Five New Software Copyrights for BP Plus in China

Founder recently bought AU$102k worth of stock

Uscom Limited Announces Two New USCOM Monitors Get Australian Tga Clearance

Non-Executive Director recently bought AU$145k worth of stock

Uscom Limited Announces SpiroSonic Air Approved for European Ce Mark

Uscom Limited Announces Two New Uscom Devices for China

First half 2021 earnings released: AU$0.002 loss per share (vs AU$0.011 loss in 1H 2020)

Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Uscom Limited Appoints MedCaT as New European Distributor

Uscom Limited announced that it has received funding

Full year earnings released - AU$0.009 loss per share

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령